Drug Discovery 2017
Poster
62

Validation of IncuCyte® live-cell labelling dyes for monitoring immune and tumour cell interactions

Objective

Fluorescent live-cell labelling dyes have proven beneficial for identifying and tracking sub-populations in mixed cell cultures. However, many are ill-suited for this purpose, limited by inconsistent or transient labelling, perturbation or passive intercellular transfer. Here, we describe experiments exemplifying the properties of new cell-labelling dyes (IncuCyte® CytoLight Rapid) designed to address these limitations.

Cells labelled with either CytoLight Rapid or competitor dyes were assessed for suitability for IncuCyte live-cell analysis. Only 4/20 competitor dyes yielded sufficiently bright and homogeneous cell labelling at concentrations that did not perturb cell proliferation. 2 of these 4 labelled cells transiently. In co-cultures, CytoLight Rapid, but not competitor dyes, exhibited little or no passive cell-to-cell transfer. Use of CytoLight Rapid was exemplified by immune/cancer cell interactions. Loss of fluorescence from CytoLight Rapid-labelled A549 cells was used to detect killing by activated immune cells, and direct interactions of CytoLight Rapid-labelled PBMCs with tumour cells expressing RFP were qualified through visualisation.

These findings demonstrate IncuCyte CytoLight Rapid dyes provide fast, bright and homogeneous cell-labelling for up to 48h without perturbing or transferring to adjacent cells. These dyes are suitable for live-cell analysis and labelling difficult to transfect cells, such as patient-derived tissues.

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2038